Changes of Tyrosine Phosphorylation in Liver and Kidney of Polycystic Ovarian Rats Induced by Letrozole

SUMMARY: Letrozole (Letro) is a drug commonly used for breast cancer treatment since it can decrease estrogen level. In experimental animal, the Letro has been used to induce the polycystic ovarian syndrome (PCOS) model. Tyrosine phosphorylation (TyrPho) is an essential process in various biological...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Chaiyamoon,Arada, Bunsueb,Sudtida, Iamsaard,Sitthichai
Lenguaje:English
Publicado: Sociedad Chilena de Anatomía 2020
Materias:
Acceso en línea:http://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0717-95022020000400919
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:scielo:S0717-95022020000400919
record_format dspace
spelling oai:scielo:S0717-950220200004009192020-09-08Changes of Tyrosine Phosphorylation in Liver and Kidney of Polycystic Ovarian Rats Induced by LetrozoleChaiyamoon,AradaBunsueb,SudtidaIamsaard,Sitthichai Letrozole Tyrosine phosphorylation Liver Kidney Rats SUMMARY: Letrozole (Letro) is a drug commonly used for breast cancer treatment since it can decrease estrogen level. In experimental animal, the Letro has been used to induce the polycystic ovarian syndrome (PCOS) model. Tyrosine phosphorylation (TyrPho) is an essential process in various biological functions both normal and abnormal conditions especially reproduction. Although some side effects of Letro are reported, the alterations of TyrPho responsible for liver and kidney functions have never been demonstrated. In this study, the blood serum, liver, and kidney of control and PCOS rats induced with Letro (orally, 1 mg/ KgBW) for consecutive 21 days were used to determine the serum biochemical components and to investigate the TyrPho expression using western blot analysis. Histopathology of such tissues was observed by Masson’s trichrome staining. The results showed that Letro did not affect histological structures but significantly increased the serum levels of urea nitrogen, cholesterol, triglyceride, HDL, LDL, ALT, AST, and alkaline phosphatase. Additionally, the TyrPho protein expressions of 32 and 27 kDas in liver and of 55 and 43 kDas in kidney were increased while of a kidney 26 kDa was decreased as compared to those of control. In conclusion, this recent study indicated that the changes of TyrPho proteins in liver and kidney induced with Letro associated with their functions by alteration of serum biochemical levels.info:eu-repo/semantics/openAccessSociedad Chilena de AnatomíaInternational Journal of Morphology v.38 n.4 20202020-08-01text/htmlhttp://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0717-95022020000400919en10.4067/S0717-95022020000400919
institution Scielo Chile
collection Scielo Chile
language English
topic Letrozole
Tyrosine phosphorylation
Liver
Kidney
Rats
spellingShingle Letrozole
Tyrosine phosphorylation
Liver
Kidney
Rats
Chaiyamoon,Arada
Bunsueb,Sudtida
Iamsaard,Sitthichai
Changes of Tyrosine Phosphorylation in Liver and Kidney of Polycystic Ovarian Rats Induced by Letrozole
description SUMMARY: Letrozole (Letro) is a drug commonly used for breast cancer treatment since it can decrease estrogen level. In experimental animal, the Letro has been used to induce the polycystic ovarian syndrome (PCOS) model. Tyrosine phosphorylation (TyrPho) is an essential process in various biological functions both normal and abnormal conditions especially reproduction. Although some side effects of Letro are reported, the alterations of TyrPho responsible for liver and kidney functions have never been demonstrated. In this study, the blood serum, liver, and kidney of control and PCOS rats induced with Letro (orally, 1 mg/ KgBW) for consecutive 21 days were used to determine the serum biochemical components and to investigate the TyrPho expression using western blot analysis. Histopathology of such tissues was observed by Masson’s trichrome staining. The results showed that Letro did not affect histological structures but significantly increased the serum levels of urea nitrogen, cholesterol, triglyceride, HDL, LDL, ALT, AST, and alkaline phosphatase. Additionally, the TyrPho protein expressions of 32 and 27 kDas in liver and of 55 and 43 kDas in kidney were increased while of a kidney 26 kDa was decreased as compared to those of control. In conclusion, this recent study indicated that the changes of TyrPho proteins in liver and kidney induced with Letro associated with their functions by alteration of serum biochemical levels.
author Chaiyamoon,Arada
Bunsueb,Sudtida
Iamsaard,Sitthichai
author_facet Chaiyamoon,Arada
Bunsueb,Sudtida
Iamsaard,Sitthichai
author_sort Chaiyamoon,Arada
title Changes of Tyrosine Phosphorylation in Liver and Kidney of Polycystic Ovarian Rats Induced by Letrozole
title_short Changes of Tyrosine Phosphorylation in Liver and Kidney of Polycystic Ovarian Rats Induced by Letrozole
title_full Changes of Tyrosine Phosphorylation in Liver and Kidney of Polycystic Ovarian Rats Induced by Letrozole
title_fullStr Changes of Tyrosine Phosphorylation in Liver and Kidney of Polycystic Ovarian Rats Induced by Letrozole
title_full_unstemmed Changes of Tyrosine Phosphorylation in Liver and Kidney of Polycystic Ovarian Rats Induced by Letrozole
title_sort changes of tyrosine phosphorylation in liver and kidney of polycystic ovarian rats induced by letrozole
publisher Sociedad Chilena de Anatomía
publishDate 2020
url http://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0717-95022020000400919
work_keys_str_mv AT chaiyamoonarada changesoftyrosinephosphorylationinliverandkidneyofpolycysticovarianratsinducedbyletrozole
AT bunsuebsudtida changesoftyrosinephosphorylationinliverandkidneyofpolycysticovarianratsinducedbyletrozole
AT iamsaardsitthichai changesoftyrosinephosphorylationinliverandkidneyofpolycysticovarianratsinducedbyletrozole
_version_ 1718445153771847680